NKGen, HekaBio Partner to Expand NK Cell Therapy in Japan
July 18, 2025
In connection with HekaBio’s recently announced strategic investment in NKGen, the partnership will expedite the regulatory, manufacturing, and commercial development of NKGen’s autologous NK cell